← FDA DRUG APPROVALS

FDA ANDA · ANDA090254

CETIRIZINE HYDROCHLORIDE

Sponsor: PERRIGO R AND D

APPLICATION
ANDA090254
TYPE
ANDA
ORIGINAL APPROVAL
2008-04-09
LATEST ACTION
2017-07-10
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Over-the-counter

Products

CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEFOver-the-counter
CETIRIZINE HYDROCHLORIDE 5MG/5ML · SOLUTION · ORAL
CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGYOver-the-counter
CETIRIZINE HYDROCHLORIDE 5MG/5ML · SOLUTION · ORAL

Approval history

2017-07-10Labeling · Supplement 20 · standardAP
2010-07-23Manufacturing (CMC) · Supplement 3AP
2009-05-28Labeling · Supplement 2AP
2008-04-09OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →